サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1631164

外用薬の市場規模、シェア、動向分析レポート：投与経路別、タイプ別、最終用途別、地域別、セグメント予測、2025年～2030年

Topical Drugs Market Size, Share & Trends Analysis Report By Route Of Administration (Dermal, Ophthalmic, Rectal, Vaginal, Nasal), By Type (Semi-solid, Transdermal), By End Use, By Region, And Segment Forecasts, 2025 - 2030

出版日
ページ情報
英文 100 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.91円
外用薬の市場規模、シェア、動向分析レポート：投与経路別、タイプ別、最終用途別、地域別、セグメント予測、2025年～2030年
出版日: 2024年12月10日
発行: Grand View Research
ページ情報: 英文 100 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

外用薬市場の成長と動向

Grand View Research Inc.の最新レポートによると、世界の外用薬市場規模は2030年までに2,693億米ドルに達する見込みです。

同産業は2025～2030年にかけてCAGR 6.0％で成長すると予測されています。産業の成長に寄与する主要要因には、主要企業間の戦略的提携と相まって、皮膚疾患の有病率の増加が含まれます。乾癬、アトピー性皮膚炎、湿疹などの皮膚感染症の有病率の増加は、目や耳の治療に対する需要の高まりと相まって、予測期間中、経皮または経皮医薬品の需要を促進すると予想されます。例えば、2021年10月、AbbVie Inc.は老眼治療用ピロカルピン塩酸塩点眼液VuityのFDA承認を取得しました。

また、NCBIによると、乾癬の有病率は欧州でほぼ1.92%、北米で1.5%です。皮膚疾患を治療する外用薬の発売も、皮膚薬の需要を促進すると予想されています。例えば、2020年9月、カナダのボシュヘルス社は、乾癬患者向けに新規の抗乾癬剤デュオブライ・ローションを発売しました。技術の進歩や、Alcon, Inc.やNovartis AGなどの主要企業間の買収・合併活動の活発化は、産業の成長を後押しすると予想されています。例えば、2022年6月、Novartis AGはKedalion Therapeuticsを買収し、これにより眼科用医薬品の正確な経皮送達を促進するAcuStream技術を獲得しました。

さらに、2022年5月にはAlcon Inc.がKala Pharmaceuticals, Inc.から眼科外用薬のEysuvis（ロテプレドノールエタボン酸懸濁液）を買収し、ドライアイ治療の既存ポートフォリオに加えました。例えば、WHOによると、世界中で年間推定1,100万件の熱傷が発生しており、そのうち約18万件が死亡しています。火傷の治療には、スルファジアジン銀クリーム、ビスマス含浸石油ガーゼ、硝酸セリウム、酢酸マフェニド、ナノ結晶銀など、さまざまな外用薬が使用されています。

外用薬市場レポートハイライト

  • ドラッグデリバリーは市場を独占し、2024年には54.1%のシェアを占めました。
  • 半固形製剤は、その汎用性、使いやすさ、有効成分を皮膚に直接送達する有効性により、2024年の売上シェア61.9%で市場をリードしました。
  • 病院・クリニックは、2024年に38.9%の最大の売上シェアを占めました。これは、専門的な介入が必要な皮膚疾患や慢性疾患の有病率の増加による。
  • 北米の外用薬市場は、皮膚疾患の高い有病率、先進的医療インフラ、研究開発への旺盛な投資が牽引し、2024年に世界市場を独占しました。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 外用薬市場の変数、動向、範囲

  • 市場系統の展望
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • ビジネス環境分析
    • 産業分析-ポーターのファイブフォース分析
    • PESTLE分析

第4章 外用薬市場： 投与経路ビジネス分析

  • 投与経路別市場シェア、2024年と2030年
  • 投与経路セグメントダッシュボード
  • 市場規模と予測と動向分析、投与経路別、2018～2030年
  • 経皮ドラッグデリバリー
  • 眼科用ドラッグデリバリー
  • 直腸内ドラッグデリバリー
  • 膣内ドラッグデリバリー
  • 鼻腔内ドラッグデリバリー

第5章 外用薬市場：タイプビジネス分析

  • タイプ別市場シェア、2024年と2030年
  • タイプセグメントダッシュボード
  • 市場規模と予測と動向分析、タイプ別、2018～2030年
  • 半固形製剤
  • 液体製剤
  • 固形製剤
  • 経皮吸収製品

第6章 外用薬市場：最終用途ビジネス分析

  • 最終用途市場シェア、2024年と2030年
  • 最終用途セグメントダッシュボード
  • 市場規模と予測と動向分析、最終用途別、2018～2030年
  • 在宅医療
  • 病院・クリニック
  • 火傷センター
  • その他の施設

第7章 外用薬市場：地域別、推定・動向分析

  • 地域別市場シェア分析、2024年と2030年
  • 地域別市場ダッシュボード
  • 市場規模と予測動向分析、2018～2030年
  • 北米
    • 国別、2018～2030年
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 国別、2018～2030年
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • ノルウェー
    • デンマーク
    • スウェーデン
  • アジア太平洋
    • 国別、2018～2030年
    • 日本
    • 中国
    • インド
    • 韓国
    • オーストラリア
    • タイ
  • ラテンアメリカ
    • 国別、2018～2030年
    • ブラジル
    • アルゼンチン
  • 中東・アフリカ
    • 国別、2018～2030年
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第8章 競合情勢

  • 参加者概要
  • 企業の市況分析
  • 企業分類
  • 戦略マッピング
  • 企業プロファイル/上場企業
    • Bayer AG
    • Cipla
    • GSK plc
    • Johnson & Johnson Services, Inc.
    • Novartis AG
    • Bausch Health Companies Inc.
    • Hisamitsu Pharmaceuticals Co., Inc.
    • Merck KGaA
    • GLENMARK PHARMACEUTICALS LTD.
    • MedPharm Ltd.
図表

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global topical drugs market, by region, 2018 - 2030 (USD Million)
  • Table 4 Global topical drugs market, by route of administration, 2018 - 2030 (USD Million)
  • Table 5 Global topical drugs market, by type, 2018 - 2030 (USD Million)
  • Table 6 Global topical drugs market, by end use, 2018 - 2030 (USD Million)
  • Table 7 North America topical drugs market, by country, 2018 - 2030 (USD Million)
  • Table 8 North America topical drugs market, by route of administration, 2018 - 2030 (USD Million)
  • Table 9 North America topical drugs market, by type, 2018 - 2030 (USD Million)
  • Table 10 North America topical drugs market, by end use, 2018 - 2030 (USD Million)
  • Table 11 U.S. topical drugs market, by route of administration, 2018 - 2030 (USD Million)
  • Table 12 U.S. topical drugs market, by type, 2018 - 2030 (USD Million)
  • Table 13 U.S. Topical drugs market, by end use, 2018 - 2030 (USD Million)
  • Table 14 Canada topical drugs market, by route of administration, 2018 - 2030 (USD Million)
  • Table 15 Canada topical drugs market, by type, 2018 - 2030 (USD Million)
  • Table 16 Canada topical drugs market, by end use, 2018 - 2030 (USD Million)
  • Table 17 Mexico topical drugs market, by route of administration, 2018 - 2030 (USD Million)
  • Table 18 Mexico topical drugs market, by type, 2018 - 2030 (USD Million)
  • Table 19 Mexico topical drugs market, by end use, 2018 - 2030 (USD Million)
  • Table 20 Europe topical drugs market, by country, 2018 - 2030 (USD Million)
  • Table 21 Europe topical drugs market, by route of administration, 2018 - 2030 (USD Million)
  • Table 22 Europe topical drugs market, by type, 2018 - 2030 (USD Million)
  • Table 23 Europe topical drugs market, by end use, 2018 - 2030 (USD Million)
  • Table 24 UK topical drugs market, by route of administration, 2018 - 2030 (USD Million)
  • Table 25 UK topical drugs market, by type, 2018 - 2030 (USD Million)
  • Table 26 UK Topical drugs market, by end use, 2018 - 2030 (USD Million)
  • Table 27 Germany topical drugs market, by route of administration, 2018 - 2030 (USD Million)
  • Table 28 Germany topical drugs market, by type, 2018 - 2030 (USD Million)
  • Table 29 Germany topical drugs market, by end use, 2018 - 2030 (USD Million)
  • Table 30 France topical drugs market, by route of administration, 2018 - 2030 (USD Million)
  • Table 31 France topical drugs market, by type, 2018 - 2030 (USD Million)
  • Table 32 France Topical drugs market, by end use, 2018 - 2030 (USD Million)
  • Table 33 Italy topical drugs market, by route of administration, 2018 - 2030 (USD Million)
  • Table 34 Italy topical drugs market, by type, 2018 - 2030 (USD Million)
  • Table 35 Italy topical drugs market, by end use, 2018 - 2030 (USD Million)
  • Table 36 Spain topical drugs market, by route of administration, 2018 - 2030 (USD Million)
  • Table 37 Spain topical drugs market, by type, 2018 - 2030 (USD Million)
  • Table 38 Spain topical drugs market, by end use, 2018 - 2030 (USD Million)
  • Table 39 Norway topical drugs market, by route of administration, 2018 - 2030 (USD Million)
  • Table 40 Norway topical drugs market, by type, 2018 - 2030 (USD Million)
  • Table 41 Norway Topical drugs market, by end use, 2018 - 2030 (USD Million)
  • Table 42 Denmark topical drugs market, by route of administration, 2018 - 2030 (USD Million)
  • Table 43 Denmark topical drugs market, by type, 2018 - 2030 (USD Million)
  • Table 44 Denmark topical drugs market, by end use, 2018 - 2030 (USD Million)
  • Table 45 Sweden topical drugs market, by route of administration, 2018 - 2030 (USD Million)
  • Table 46 Sweden topical drugs market, by type, 2018 - 2030 (USD Million)
  • Table 47 Sweden topical drugs market, by end use, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific topical drugs market, by country, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific topical drugs market, by route of administration, 2018 - 2030 (USD Million)
  • Table 50 Asia Pacific topical drugs market, by type, 2018 - 2030 (USD Million)
  • Table 51 Asia Pacific topical drugs market, by end use, 2018 - 2030 (USD Million)
  • Table 52 Japan topical drugs market, by route of administration, 2018 - 2030 (USD Million)
  • Table 53 Japan topical drugs market, by type, 2018 - 2030 (USD Million)
  • Table 54 Japan topical drugs market, by end use, 2018 - 2030 (USD Million)
  • Table 55 China topical drugs market, by route of administration, 2018 - 2030 (USD Million)
  • Table 56 China topical drugs market, by type, 2018 - 2030 (USD Million)
  • Table 57 China topical drugs market, by end use, 2018 - 2030 (USD Million)
  • Table 58 India topical drugs market, by route of administration, 2018 - 2030 (USD Million)
  • Table 59 India topical drugs market, by type, 2018 - 2030 (USD Million)
  • Table 60 India topical drugs market, by end use, 2018 - 2030 (USD Million)
  • Table 61 Australia topical drugs market, by route of administration, 2018 - 2030 (USD Million)
  • Table 62 Australia topical drugs market, by type, 2018 - 2030 (USD Million)
  • Table 63 Australia topical drugs market, by end use, 2018 - 2030 (USD Million)
  • Table 64 South Korea topical drugs market, by route of administration, 2018 - 2030 (USD Million)
  • Table 65 South Korea topical drugs market, by type, 2018 - 2030 (USD Million)
  • Table 66 South Korea topical drugs market, by end use, 2018 - 2030 (USD Million)
  • Table 67 Thailand topical drugs market, by route of administration, 2018 - 2030 (USD Million)
  • Table 68 Thailand topical drugs market, by type, 2018 - 2030 (USD Million)
  • Table 69 Thailand topical drugs market, by end use, 2018 - 2030 (USD Million)
  • Table 70 Latin America topical drugs market, by country, 2018 - 2030 (USD Million)
  • Table 71 Latin America topical drugs market, by route of administration, 2018 - 2030 (USD Million)
  • Table 72 Latin America topical drugs market, by type, 2018 - 2030 (USD Million)
  • Table 73 Latin America topical drugs market, by end use, 2018 - 2030 (USD Million)
  • Table 74 Brazil topical drugs market, by route of administration, 2018 - 2030 (USD Million)
  • Table 75 Brazil topical drugs market, by type, 2018 - 2030 (USD Million)
  • Table 76 Brazil topical drugs market, by end use, 2018 - 2030 (USD Million)
  • Table 77 Argentina topical drugs market, by route of administration, 2018 - 2030 (USD Million)
  • Table 78 Argentina topical drugs market, by type, 2018 - 2030 (USD Million)
  • Table 79 Argentina topical drugs market, by end use, 2018 - 2030 (USD Million)
  • Table 80 Middle East & Africa Topical drugs market, by country, 2018 - 2030 (USD Million)
  • Table 81 Middle East & Africa topical drugs market, by route of administration, 2018 - 2030 (USD Million)
  • Table 82 Middle East & Africa topical drugs market, by type, 2018 - 2030 (USD Million)
  • Table 83 Middle East & Africa topical drugs market, by end use, 2018 - 2030 (USD Million)
  • Table 84 South Africa topical drugs market, by route of administration, 2018 - 2030 (USD Million)
  • Table 85 South Africa topical drugs market, by type, 2018 - 2030 (USD Million)
  • Table 86 South Africa topical drugs market, by end use, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia topical drugs market, by route of administration, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia topical drugs market, by type, 2018 - 2030 (USD Million)
  • Table 89 Saudi Arabia topical drugs market, by end use, 2018 - 2030 (USD Million)
  • Table 90 UAE topical drugs market, by route of administration, 2018 - 2030 (USD Million)
  • Table 91 UAE topical drugs market, by type, 2018 - 2030 (USD Million)
  • Table 92 UAE topical drugs market, by end use, 2018 - 2030 (USD Million)
  • Table 93 Kuwait topical drugs market, by route of administration, 2018 - 2030 (USD Million)
  • Table 94 Kuwait topical drugs market, by type, 2018 - 2030 (USD Million)
  • Table 95 Kuwait topical drugs market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Topical drugs market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot
  • Fig. 9 Route of administration and type outlook (USD Million)
  • Fig. 10 End use outlook (USD Million)
  • Fig. 11 Competitive landscape
  • Fig. 12 Topical drugs market dynamics
  • Fig. 13 Topical drugs market: Porter's five forces analysis
  • Fig. 14 Topical drugs market: PESTLE analysis
  • Fig. 15 Topical drugs market: Route of administration segment dashboard
  • Fig. 16 Topical drugs market: Route of administration market share analysis, 2024 & 2030
  • Fig. 17 Dermal drug delivery market, 2018 - 2030 (USD Million)
  • Fig. 18 Ophthalmic drug delivery market, 2018 - 2030 (USD Million)
  • Fig. 19 Rectal drug delivery market, 2018 - 2030 (USD Million)
  • Fig. 20 Vaginal drug delivery market, 2018 - 2030 (USD Million)
  • Fig. 21 Nasal drug delivery market, 2018 - 2030 (USD Million)
  • Fig. 22 Topical drugs market: Type segment dashboard
  • Fig. 23 Topical drugs market: Type market share analysis, 2024 & 2030
  • Fig. 24 Semi-solid formulations market, 2018 - 2030 (USD Million)
  • Fig. 25 Creams market, 2018 - 2030 (USD Million)
  • Fig. 26 Ointments market, 2018 - 2030 (USD Million)
  • Fig. 27 Lotions market, 2018 - 2030 (USD Million)
  • Fig. 28 Gel market, 2018 - 2030 (USD Million)
  • Fig. 29 Pastes market, 2018 - 2030 (USD Million)
  • Fig. 30 Liquid formulations market, 2018 - 2030 (USD Million)
  • Fig. 31 Suspensions market, 2018 - 2030 (USD Million)
  • Fig. 32 Solutions market, 2018 - 2030 (USD Million)
  • Fig. 33 Solid formulations market, 2018 - 2030 (USD Million)
  • Fig. 34 Powders market, 2018 - 2030 (USD Million)
  • Fig. 35 Suppositories market, 2018 - 2030 (USD Million)
  • Fig. 36 Transdermal products market, 2018 - 2030 (USD Million)
  • Fig. 37 Transdermal patches market, 2018 - 2030 (USD Million)
  • Fig. 38 Transdermal semi-solids market, 2018 - 2030 (USD Million)
  • Fig. 39 Topical drugs market: End use segment dashboard
  • Fig. 40 Topical drugs market: End use market share analysis, 2024 & 2030
  • Fig. 41 Home care settings market, 2018 - 2030 (USD Million)
  • Fig. 42 Hospitals & clinics market, 2018 - 2030 (USD Million)
  • Fig. 43 Burn centers market, 2018 - 2030 (USD Million)
  • Fig. 44 Other facilities market, 2018 - 2030 (USD Million)
  • Fig. 45 Topical drugs market revenue, by region
  • Fig. 46 Regional marketplace: Key takeaways
  • Fig. 47 Regional marketplace: Key takeaways
  • Fig. 48 North America topical drugs market, 2018 - 2030 (USD Million)
  • Fig. 49 U.S. country dynamics
  • Fig. 50 U.S. topical drugs market, 2018 - 2030 (USD Million)
  • Fig. 51 Canada country dynamics
  • Fig. 52 Canada topical drugs market, 2018 - 2030 (USD Million)
  • Fig. 53 Mexico country dynamics
  • Fig. 54 Mexico topical drugs market, 2018 - 2030 (USD Million)
  • Fig. 55 Europe topical drugs market, 2018 - 2030 (USD Million)
  • Fig. 56 UK country dynamics
  • Fig. 57 UK topical drugs market, 2018 - 2030 (USD Million)
  • Fig. 58 Germany country dynamics
  • Fig. 59 Germany topical drugs market, 2018 - 2030 (USD Million)
  • Fig. 60 France country dynamics
  • Fig. 61 France topical drugs market, 2018 - 2030 (USD Million)
  • Fig. 62 Italy country dynamics
  • Fig. 63 Italy topical drugs market, 2018 - 2030 (USD Million)
  • Fig. 64 Spain country dynamics
  • Fig. 65 Spain topical drugs market, 2018 - 2030 (USD Million)
  • Fig. 66 Norway country dynamics
  • Fig. 67 Norway topical drugs market, 2018 - 2030 (USD Million)
  • Fig. 68 Sweden country dynamics
  • Fig. 69 Sweden topical drugs market, 2018 - 2030 (USD Million)
  • Fig. 70 Denmark country dynamics
  • Fig. 71 Denmark topical drugs market, 2018 - 2030 (USD Million)
  • Fig. 72 Asia Pacific topical drugs market, 2018 - 2030 (USD Million)
  • Fig. 73 Japan country dynamics
  • Fig. 74 Japan topical drugs market, 2018 - 2030 (USD Million)
  • Fig. 75 China country dynamics
  • Fig. 76 China topical drugs market, 2018 - 2030 (USD Million)
  • Fig. 77 India country dynamics
  • Fig. 78 India topical drugs market, 2018 - 2030 (USD Million)
  • Fig. 79 Australia country dynamics
  • Fig. 80 Australia topical drugs market, 2018 - 2030 (USD Million)
  • Fig. 81 South Korea country dynamics
  • Fig. 82 South Korea topical drugs market, 2018 - 2030 (USD Million)
  • Fig. 83 Thailand country dynamics
  • Fig. 84 Thailand topical drugs market, 2018 - 2030 (USD Million)
  • Fig. 85 Latin America topical drugs market, 2018 - 2030 (USD Million)
  • Fig. 86 Brazil country dynamics
  • Fig. 87 Brazil topical drugs market, 2018 - 2030 (USD Million)
  • Fig. 88 Argentina country dynamics
  • Fig. 89 Argentina topical drugs market, 2018 - 2030 (USD Million)
  • Fig. 90 MEA topical drugs market, 2018 - 2030 (USD Million)
  • Fig. 91 South Africa country dynamics
  • Fig. 92 South Africa topical drugs market, 2018 - 2030 (USD Million)
  • Fig. 93 Saudi Arabia country dynamics
  • Fig. 94 Saudi Arabia topical drugs market, 2018 - 2030 (USD Million)
  • Fig. 95 UAE country dynamics
  • Fig. 96 UAE topical drugs market, 2018 - 2030 (USD Million)
  • Fig. 97 Kuwait country dynamics
  • Fig. 98 Kuwait topical drugs market, 2018 - 2030 (USD Million)
  • Fig. 99 Company categorization
  • Fig. 100 Company market position analysis
  • Fig. 101 Strategic framework
目次
Product Code: GVR-4-68039-959-4

Topical Drugs Market Growth & Trends:

The global topical drugs market size is expected to reach USD 269.3 billion by 2030, according to a new report by Grand View Research Inc. The industry is expected to grow at a CAGR of 6.0% from 2025 to 2030. The key factors contributing to the industry growth include the increased prevalence of skin disorders coupled with strategic collaborations between key players. The increasing prevalence of skin infections, such as psoriasis, atopic dermatitis, and eczema, coupled with the rising demand for eye and ear therapies is expected to drive the demand for transdermal or dermal medicines during the forecast period. For instance, in October 2021, AbbVie Inc. received FDA approval for Vuity, a pilocarpine HCl ophthalmic solution for treating presbyopia.

In addition, according to the NCBI, the prevalence of psoriasis is nearly 1.92% and 1.5% among European and North American populations. The launch of topical medicines to treat skin diseases is also anticipated to propel the demand for dermal drugs. For instance, in September 2020, Bausch Health, Canada launched a novel antipsoriatic agent, Duobrii lotion for psoriasis patients.Advancements in technology and increased acquisitions and mergers activities among key players, such as Alcon, Inc. and Novartis AG, are anticipated to boost the industry's growth. For instance, in June 2022, Novartis AG acquired Kedalion Therapeutics, thereby acquiring AcuStream technology to facilitate accurate dermal delivery of ophthalmic medicines.

Moreover, in May 2022, Alcon Inc. acquired Eysuvis (loteprednol etabonate suspension) for topical ophthalmic use from Kala Pharmaceuticals, Inc., thereby adding to its existing portfolio of dry eye drugs.A high incidence of burn injuries is expected to render high utilization of topical medicines in treating burn injuries. For instance, according to the WHO, an estimated 11 million burn injuries occur annually worldwide, out of which about 180,000 cases are fatal. Various topical agents are used in treating burn injuries including silver sulfadiazine cream, bismuth-impregnated petroleum gauze, cerium nitrate, mafenide acetate, and nanocrystalline silver among others.

Topical Drugs Market Report Highlights:

  • Dermal drug delivery dominated the market and accounted for a share of 54.1% in 2024, fueled by its capacity to offer targeted treatment, user-friendly application, and improved patient compliance.
  • Semi-solid formulations led the market with a revenue share of 61.9% in 2024 due to their versatility, ease of use, and effectiveness in delivering active ingredients directly to the skin.
  • Hospitals & clinics held the largest revenue share of 38.9% in 2024, driven by the growing prevalence of skin disorders and chronic diseases necessitating professional intervention.
  • North America topical drugs market dominated the global market in 2024, driven by a high prevalence of skin disorders, advanced healthcare infrastructure, and robust investments in research and development.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Route of Administration
    • 1.2.2. Type
    • 1.2.3. End Use
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Topical Drugs Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis

Chapter 4. Topical Drugs Market: Route of Administration Business Analysis

  • 4.1. Route of Administration Market Share, 2024 & 2030
  • 4.2. Route of Administration Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Route of Administration, 2018 to 2030 (USD Million)
  • 4.4. Dermal Drug Delivery
    • 4.4.1. Dermal Drug Delivery Market, 2018 - 2030 (USD Million)
  • 4.5. Ophthalmic Drug Delivery
    • 4.5.1. Ophthalmic Drug Delivery Market, 2018 - 2030 (USD Million)
  • 4.6. Rectal Drug Delivery
    • 4.6.1. Rectal Drug Delivery Market, 2018 - 2030 (USD Million)
  • 4.7. Vaginal Drug Delivery
    • 4.7.1. Vaginal Drug Delivery Market, 2018 - 2030 (USD Million)
  • 4.8. Nasal Drug Delivery
    • 4.8.1. Nasal Drug Delivery Market, 2018 - 2030 (USD Million)

Chapter 5. Topical Drugs Market: Type Business Analysis

  • 5.1. Type Market Share, 2024 & 2030
  • 5.2. Type Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by Type, 2018 to 2030 (USD Million)
  • 5.4. Semi-solid Formulations
    • 5.4.1. Semi-solid Formulations Market, 2018 - 2030 (USD Million)
    • 5.4.2. Creams
      • 5.4.2.1. Creams Market, 2018 - 2030 (USD Million)
    • 5.4.3. Ointments
      • 5.4.3.1. Ointments Market, 2018 - 2030 (USD Million)
    • 5.4.4. Lotions
      • 5.4.4.1. Lotions Market, 2018 - 2030 (USD Million)
    • 5.4.5. Gel
      • 5.4.5.1. Gel Market, 2018 - 2030 (USD Million)
    • 5.4.6. Pastes
      • 5.4.6.1. Pastes Market, 2018 - 2030 (USD Million)
  • 5.5. Liquid Formulations
    • 5.5.1. Liquid Formulations Market, 2018 - 2030 (USD Million)
    • 5.5.2. Suspensions
      • 5.5.2.1. Suspensions Market, 2018 - 2030 (USD Million)
    • 5.5.3. Solutions
      • 5.5.3.1. Solutions Market, 2018 - 2030 (USD Million)
  • 5.6. Solid Formulations
    • 5.6.1. Solid Formulations Market, 2018 - 2030 (USD Million)
    • 5.6.2. Powders
      • 5.6.2.1. Powders Market, 2018 - 2030 (USD Million)
    • 5.6.3. Suppositories
      • 5.6.3.1. Suppositories Market, 2018 - 2030 (USD Million)
  • 5.7. Transdermal Products
    • 5.7.1. Transdermal Products Market, 2018 - 2030 (USD Million)
    • 5.7.2. Transdermal Patches
      • 5.7.2.1. Transdermal Patches Market, 2018 - 2030 (USD Million)
    • 5.7.3. Transdermal Semi-Solids
      • 5.7.3.1. Transdermal Semi-Solids Market, 2018 - 2030 (USD Million)

Chapter 6. Topical Drugs Market: End Use Business Analysis

  • 6.1. End Use Market Share, 2024 & 2030
  • 6.2. End Use Segment Dashboard
  • 6.3. Market Size & Forecasts and Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 6.4. Home Care Settings
    • 6.4.1. Home Care Settings Market, 2018 - 2030 (USD Million)
  • 6.5. Hospitals & Clinics
    • 6.5.1. Hospitals & Clinics Market, 2018 - 2030 (USD Million)
  • 6.6. Burn Centers
    • 6.6.1. Burn Centers Market, 2018 - 2030 (USD Million)
  • 6.7. Other Facilities
    • 6.7.1. Other Facilities Market, 2018 - 2030 (USD Million)

Chapter 7. Topical Drugs Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2024 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030
  • 7.4. North America
    • 7.4.1. North America Topical Drugs Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 7.4.2. U.S.
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Regulatory Framework
      • 7.4.2.3. Competitive Insights
      • 7.4.2.4. U.S. Topical Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.4.3. Canada
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Regulatory Framework
      • 7.4.3.3. Competitive Insights
      • 7.4.3.4. Canada Topical Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.4.4. Mexico
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Regulatory Framework
      • 7.4.4.3. Competitive Insights
      • 7.4.4.4. Mexico Topical Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Europe
    • 7.5.1. Europe Topical Drugs Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 7.5.2. UK
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Regulatory Framework
      • 7.5.2.3. Competitive Insights
      • 7.5.2.4. UK Topical Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. Germany
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Regulatory Framework
      • 7.5.3.3. Competitive Insights
      • 7.5.3.4. Germany Topical Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.4. France
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Regulatory Framework
      • 7.5.4.3. Competitive Insights
      • 7.5.4.4. France Topical Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.5. Italy
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Regulatory Framework
      • 7.5.5.3. Competitive Insights
      • 7.5.5.4. Italy Topical Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.6. Spain
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Regulatory Framework
      • 7.5.6.3. Competitive Insights
      • 7.5.6.4. Spain Topical Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.7. Norway
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Regulatory Framework
      • 7.5.7.3. Competitive Insights
      • 7.5.7.4. Norway Topical Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.8. Denmark
      • 7.5.8.1. Key Country Dynamics
      • 7.5.8.2. Regulatory Framework
      • 7.5.8.3. Competitive Insights
      • 7.5.8.4. Denmark Topical Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.9. Sweden
      • 7.5.9.1. Key Country Dynamics
      • 7.5.9.2. Regulatory Framework
      • 7.5.9.3. Competitive Insights
      • 7.5.9.4. Sweden Topical Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Asia Pacific Topical Drugs Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 7.6.2. Japan
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Regulatory Framework
      • 7.6.2.3. Competitive Insights
      • 7.6.2.4. Japan Topical Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. China
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Regulatory Framework
      • 7.6.3.3. Competitive Insights
      • 7.6.3.4. China Topical Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.4. India
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Regulatory Framework
      • 7.6.4.3. Competitive Insights
      • 7.6.4.4. India Topical Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.5. South Korea
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Regulatory Framework
      • 7.6.5.3. Competitive Insights
      • 7.6.5.4. South Korea Topical Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.6. Australia
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Regulatory Framework
      • 7.6.6.3. Competitive Insights
      • 7.6.6.4. Australia Topical Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.7. Thailand
      • 7.6.7.1. Key Country Dynamics
      • 7.6.7.2. Regulatory Framework
      • 7.6.7.3. Competitive Insights
      • 7.6.7.4. Thailand Topical Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Latin America Topical Drugs Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 7.7.2. Brazil
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Regulatory Framework
      • 7.7.2.3. Competitive Insights
      • 7.7.2.4. Brazil Topical Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.7.3. Argentina
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Regulatory Framework
      • 7.7.3.3. Competitive Insights
      • 7.7.3.4. Argentina Topical Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.8. MEA
    • 7.8.1. MEA Topical Drugs Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 7.8.2. South Africa
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Regulatory Framework
      • 7.8.2.3. Competitive Insights
      • 7.8.2.4. South Africa Topical Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Regulatory Framework
      • 7.8.3.3. Competitive Insights
      • 7.8.3.4. Saudi Arabia Topical Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.8.4. UAE
      • 7.8.4.1. Key Country Dynamics
      • 7.8.4.2. Regulatory Framework
      • 7.8.4.3. Competitive Insights
      • 7.8.4.4. UAE Topical Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.8.5. Kuwait
      • 7.8.5.1. Key Country Dynamics
      • 7.8.5.2. Regulatory Framework
      • 7.8.5.3. Competitive Insights
      • 7.8.5.4. Kuwait Topical Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Participant Overview
  • 8.2. Company Market Position Analysis
  • 8.3. Company Categorization
  • 8.4. Strategy Mapping
  • 8.5. Company Profiles/Listing
    • 8.5.1. Bayer AG
      • 8.5.1.1. Overview
      • 8.5.1.2. Financial Performance
      • 8.5.1.3. Product Benchmarking
      • 8.5.1.4. Strategic Initiatives
    • 8.5.2. Cipla
      • 8.5.2.1. Overview
      • 8.5.2.2. Financial Performance
      • 8.5.2.3. Product Benchmarking
      • 8.5.2.4. Strategic Initiatives
    • 8.5.3. GSK plc
      • 8.5.3.1. Overview
      • 8.5.3.2. Financial Performance
      • 8.5.3.3. Product Benchmarking
      • 8.5.3.4. Strategic Initiatives
    • 8.5.4. Johnson & Johnson Services, Inc.
      • 8.5.4.1. Overview
      • 8.5.4.2. Financial Performance
      • 8.5.4.3. Product Benchmarking
      • 8.5.4.4. Strategic Initiatives
    • 8.5.5. Novartis AG
      • 8.5.5.1. Overview
      • 8.5.5.2. Financial Performance
      • 8.5.5.3. Product Benchmarking
      • 8.5.5.4. Strategic Initiatives
    • 8.5.6. Bausch Health Companies Inc.
      • 8.5.6.1. Overview
      • 8.5.6.2. Financial Performance
      • 8.5.6.3. Product Benchmarking
      • 8.5.6.4. Strategic Initiatives
    • 8.5.7. Hisamitsu Pharmaceuticals Co., Inc.
      • 8.5.7.1. Overview
      • 8.5.7.2. Financial Performance
      • 8.5.7.3. Product Benchmarking
      • 8.5.7.4. Strategic Initiatives
    • 8.5.8. Merck KGaA
      • 8.5.8.1. Overview
      • 8.5.8.2. Financial Performance
      • 8.5.8.3. Product Benchmarking
      • 8.5.8.4. Strategic Initiatives
    • 8.5.9. GLENMARK PHARMACEUTICALS LTD.
      • 8.5.9.1. Overview
      • 8.5.9.2. Financial Performance
      • 8.5.9.3. Product Benchmarking
      • 8.5.9.4. Strategic Initiatives
    • 8.5.10. MedPharm Ltd.
      • 8.5.10.1. Overview
      • 8.5.10.2. Financial Performance
      • 8.5.10.3. Product Benchmarking
      • 8.5.10.4. Strategic Initiatives